Researchers show how cells open 'doors' to release neurotransmitters
Cornell researchers have shed new light on this lightning-quick, impossibly small-scale process, called exocytosis, by casting sharp focus on what happens right at the moment the "doors" on the cell wall open.
Publishing online Oct. 11 in Proceedings of the National Academy of Sciences, researchers led by Cornell's Manfred Lindau used a combination of molecular biology, electrophysiology, microfabricated electrochemical sensors and advanced microscopy to elucidate exocytosis of noradrenaline. This is a neurotransmitter released from the adrenal gland by a type of neuroendocrine cell called a chromaffin cell.
Lindau, professor of applied and engineering physics, studies the properties of exocytosis by looking at how packets of chemicals called vesicles adhere to the cell wall and open the door between the vesicle interior and cell's exterior. This "door" is called the fusion pore.
"Biochemists have been working on experiments to identify what proteins and molecules are the main players in this mechanism of release," Lindau said.
It turns out that neurotransmitter release is largely regulated by a set of proteins called SNARE proteins, and one called synaptobrevin is located on the cell's vesicle membrane. The synaptobrevins bind with other proteins called syntaxin and SNAP-25, which are located in the plasma membrane that encloses the cell. When the cell is excited and the neurotransmitter release is triggered, these proteins together are believed to open the fusion pore.
Lindau's team of researchers used genetically altered mouse embryos that lacked synaptobrevin and introduced viruses with modified versions of the protein into their experiments. They then imaged and studied the release function of the cells for the different versions of the synaptobrevins.
They discovered that one end of the synaptobrevin -- the part that anchors it in the vesicle membrane -- is pulled deeper into the vesicle membrane when the cell is stimulated. This movement is what temporarily changes the structure of the membrane and allows the opening of the fusion pore and neurotransmitter release. It had previously been thought that the fusion pore originates by an indirect effect of the SNARE protein in the membrane lipids. Lindau's experiments have shown that the vesicle membrane component of synaptobrevin is the active part of the molecular nanomachine that forms the fusion pore.
To continue visualizing the molecular details of this complex process, Lindau is working on sabbatical at the University of Oxford with professor Mark Sansom on molecular dynamics and computer simulations of the SNARE proteins and neurotransmitter exocytosis.
The research published in PNAS was funded primarily by the National Institutes of Health and the Cornell Nanobiotechnology Center, which is supported by the National Science Foundation. The paper's authors include former Cornell graduate students Annita Ngatchou and Kassandra Kisler, postdoctoral associates Qinghua Fang and Yong Zhao, and collaborators from the Max Planck Institute for Biophysical Chemistry, the University of Saarland in Germany and the University of Copenhagen.
Most read news
Other news from the department science
These products might interest you
Hydrosart® Ultrafilter by Sartorius
Efficient ultrafiltration for biotech and pharma
Maximum flow rates and minimum protein loss with Hydrosart® membranes
Hydrosart® Microfilter by Sartorius
Hydrophilic microfilters for bioprocesses
Minimal protein adsorption and high flow rates
Polyethersulfone Ultrafilter by Sartorius
Reliable filtration with PESU membranes
Perfect for biotechnology and pharmaceuticals, withstands sterilisation and high temperatures
Polyethersulfone Microfilter by Sartorius
Biotechnological filtration made easy
Highly stable 0.1 µm PESU membranes for maximum efficiency
Sartobind® Rapid A by Sartorius
Efficient chromatography with disposable membranes
Increase productivity and reduce costs with fast cycle times
Sartopore® Platinum by Sartorius
Efficient filtration with minimal protein adsorption
Reduces rinsing volume by 95 % and offers 1 m² filtration area per 10"
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.